ArticleCureus2025
Gastric Antral Vascular Ectasia Preceding the Diagnosis of Limited Cutaneous Systemic Sclerosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic sclerosis is an autoimmune connective tissue disease that affects multiple organ systems, leading to diverse clinical presentations. Raynaud's phenomenon is one of the most common early manifestations, reflecting the underlying vasculopathy. In rare cases, vascular changes also involve internal organs, including the gastrointestinal tract. We present the case of a 79-year-old female who first presented in 2015 with recurrent iron-deficiency anaemia requiring multiple blood transfusions. Oesophago-gastro-duodenoscopy revealed features of "watermelon stomach," consistent with gastric antral vascular ectasia (GAVE). She underwent multiple sessions of argon plasma coagulation to control bleeding. Seven to eight years later, she developed classical features of systemic sclerosis, including sclerodactyly, worsening Raynaud's phenomenon, skin calcifications, and digital ulcerations. Autoimmune testing was positive for antinuclear antibodies, anti-Ro, and anti-centromere antibodies, confirming limited cutaneous systemic sclerosis. This case demonstrates the potential for GAVE to appear before other features of systemic sclerosis become clinically evident. Patients presenting with idiopathic or recurrent GAVE should be evaluated for underlying connective tissue disease, as timely recognition can influence monitoring, treatment, and long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.